TASER International Goes to Market With New TASER Shockwave Area Denial System

SCOTTSDALE, Ariz., March 30, 2009 (GLOBE NEWSWIRE) -- TASER International, Inc.
(Nasdaq:TASR), a leading provider of technology solutions and the market leader
in electronic control devices (ECDs), today announced that it will begin selling
the TASER(r) Shockwave(tm) area denial system to tactical law enforcement,
corrections, homeland security, critical infrastructure and military customers
on March 31, 2009.

"The TASER Shockwave system provides a tactical intermediate-force area denial
option for law enforcement, corrections, homeland security, and military
personnel," said Rick Smith, CEO and founder of TASER International. "The
Shockwave system is a mobile, remote force-multiplier which uses our proven
TASER Neuro Muscular Incapacitation technology to deny access to strategically
important areas."

The basic Shockwave unit consists of a six-shot TASER ECD that covers a
20-degree arc with 25-ft XP TASER(r) cartridges. The Shockwave is designed as a
fully modular system, allowing the end user complete flexibility to deploy as
needed to achieve the desired objective. The units can be stacked side-by-side,
vertically, or can be 'daisy-chained' together in limitless combinations to
allow an optimized response for every deployment.

Shockwave devices are available as either a single unit, or in three-unit and
six-unit system kits complete with cables, power magazines, recharging assembly,
and control box.

More information on the TASER Shockwave area denial system is available at
http://www.taser.com/products/law/Pages/ShockwaveLE.aspx.

About TASER International, Inc.

TASER International's products protect life and truth. TASER provides advanced
Electronic Control Devices (ECDs) and technology solutions for use in the law
enforcement, corrections, medical, military, professional security, and personal
protection markets. TASER devices use proprietary technology to incapacitate
dangerous, combative, or high-risk subjects who pose a risk to law enforcement
officers, critical infrastructure, innocent citizens, or themselves in a manner
that is generally recognized as a safer alternative to other uses of force. For
more information, please call TASER International at (800) 978-2737 or visit our
website at www.TASER.com.

The TASER International logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=2931

Note to Investors

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act"),
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), including statements, without limitation, regarding our
expectations, beliefs, intentions or strategies regarding the future. We intend
that such forward-looking statements be subject to the safe-harbor provided by
the Private Securities Litigation Reform Act of 1995. The forward-looking
information is based upon current information and expectations regarding TASER
International. These estimates and statements speak only as of the date on which
they are made, are not guarantees of future performance, and involve certain
risks, uncertainties and assumptions that are difficult to predict. Therefore,
actual outcomes and results could materially differ from what is expressed,
implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in
this press release. These statements are qualified by important factors that
could cause our actual results to differ materially from those reflected by the
forward-looking statements. Such factors include but are not limited to: (1)
market acceptance of our products; (2) our ability to establish and expand
direct and indirect distribution channels; (3) our ability to attract and retain
the endorsement of key opinion-leaders in the law enforcement community; (4) the
level of product technology and price competition for our products; (5) the
degree and rate of growth of the markets in which we compete and the
accompanying demand for our products; (6) risks associated with rapid
technological change and new product introductions; (7) competition; (8)
litigation including lawsuits resulting from alleged product related injuries
and death; (9) media publicity concerning allegations of deaths and injuries
occurring after use of the TASER device and the negative effect this publicity
could have on our sales; (10) TASER device tests and reports; (11) product
quality; (12) implementation of manufacturing automation; (13) potential
fluctuations in our quarterly operating results; (14) financial and budgetary
constraints of prospects and customers; (15) order delays; (16) dependence upon
sole and limited source suppliers; (17) negative reports concerning the TASER
device; (18) fluctuations in component pricing; (19) government regulations and
inquiries; (20) dependence upon key employees and our ability to retain
employees; (21) execution and implementation risks of new technology; (22)
ramping manufacturing production to meet demand; (23) medical and safety
studies; (24) field test results; and (25) other factors detailed in our filings
with the Securities and Exchange Commission, including, without limitation,
those factors detailed in the Company's Annual Report on Form 10-K and its Form
10-Qs.

The statements made herein are independent statements of TASER International.
The inclusion of any third parties does not represent an endorsement of any
TASER International products or services by any such third parties.

-0-
CONTACT: TASER International, Inc.
Steve Tuttle, Vice President of Communications
Media ONLY Hotline: (480) 444-4000